Nvidia reports better-than-expected fourth-quarter earnings as revenue jumps 78% on demand for the company’s ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the ...

Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Health-care company stocks declined. Moderna shares fell after reports that federal health officials are re-evaluating its $590 million contract to help develop a bird-flu vaccine. Shares of Teladoc ...

While the details surrounding the new virus are still unfolding, the market's reaction reflects concern over the potential ...

Vaccine maker Moderna had no Valentine’s Day chocolates for investors when its financial results came out Friday. The company ...

Moderna’s shares are extremely volatile and ... So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.

Allspring Global Investments Holdings LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 12.2% in the fourth quarter, Holdings Channel reports. The firm owned 15,368 shares of ...